Amarin Corporation plc (AMRN)

NasdaqCM: AMRN · 实时价格 · USD

14.39

+0.14 (0.98%)

收盘价： Sep 09, 2026, 3:59 PM

提醒

Alert

股价、关键数字和最新消息，都在这一页。

0.98% (1D)

买价	12.14
市值	304M
营收（TTM）	186M
净利润（TTM）	-27.1M
	0.76
	-1.21
	n/a
	14.68
市净率（TTM）	0.68
市销率（TTM）	1.62
财报日期	Apr 29, 2021

卖价	16.26
成交量	32,524
20日均量	77,721
开盘价	14.17
前收盘价	14.25
日内区间	14.07 - 14.39
52周区间	12.96 - 20.90
分析师	n/a
目标价	12.5 (-13.13%)
分红	n/a
除息日	n/a

关于 AMRN

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesale...

[阅读更多]

行业 Drug Manufacturers - General

板块 Healthcare

上市日期 Apr 1, 1993

员工人数 80

交易所 NasdaqCM

股票代码 AMRN

官网 https://www.amarincorp.com

公司完整简介

财务表现

2025年，Amarin plc的营收为213.65M，较上一年的228.61M下降-6.55%。净利润为-38.8M，下降-52.79%。

财务报表

分析师预测

根据2位分析师的评级，AMRN的平均评级为“null”。12个月目标价为12.5，较最新价格下跌空间13.13%。

股票预测

财报意外

Amarin plc 已于 Jul 29, 2026 发布季度财报：

营收为 $42.21M 低于预期 $0, ， -41.97% 同比下滑.
每股收益为 -0.02 低于预期 -0.01, ， 95.00% 同比增长.

下次财报发布时间

Amarin Corporation plc 的下次财报预计于 Apr 29, 2021, 开盘前。
分析师预计营收为 ... 升级

股价变动原因

新闻

11小时前 · Zacks

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Here is how Amarin (AMRN) and Royalty Pharma (RPRX) have performed compared to their sector so far this year.

1周前 · MT Newswires

European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading

European equities traded in the US as American depositary receipts were trending slightly higher lat

2周前 · MT Newswires

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

European equities traded in the US as American depositary receipts were tracking lower late Wednesda

2周前 · InvestorsHub

Amarin to Present New REDUCE-IT and EPA Analyses at ESC Congress 2026

Amarin Corporation plc (NASDAQ:AMRN) will present new REDUCE-IT and EPA analyses at the European Society of Cardiology Congress 2026, adding further research around icosapent ethyl, cardiovascular ris...

4周前 · MT Newswires

European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading

European equities traded in the US as American depositary receipts were edging lower late Wednesday

第 1 页，共 2 页

Amarin Corporation plc (AMRN)